Mosaic ImmunoEngineering, Inc.
CPMV
$0.897
$0.39980.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -34.01% | -26.09% | -27.84% | -23.48% | -21.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.60% | -35.00% | -37.16% | -38.03% | -38.12% |
| Operating Income | 41.60% | 35.00% | 37.16% | 38.03% | 38.12% |
| Income Before Tax | 43.17% | 9.51% | 8.58% | 14.45% | -13.73% |
| Income Tax Expenses | -- | -- | 0.00% | -100.00% | -100.00% |
| Earnings from Continuing Operations | 42.77% | 9.25% | 8.56% | 14.61% | -13.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.77% | 9.25% | 8.56% | 14.61% | -13.47% |
| EBIT | 41.60% | 35.00% | 37.16% | 38.03% | 38.12% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 42.77% | 9.27% | 8.54% | 14.63% | -13.57% |
| Normalized Basic EPS | 42.84% | 34.70% | 35.48% | 35.47% | 32.84% |
| EPS Diluted | 41.62% | 9.03% | 8.36% | 14.81% | -15.12% |
| Normalized Diluted EPS | 42.84% | 31.84% | 33.02% | 33.36% | 30.83% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | -4.40% | -4.40% | -4.40% | -4.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |